MedTrace Logo

Malaria Treatment With Injectable ArteSunate

NCT01828333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2013-09-13

No results posted yet for this study

Summary

The MATIAS study aims to demonstrate through limited scope implementation studies how injectable artesunate may be progressively rolled out nationwide in the Democratic Republic of the Congo as the preferred treatment for severe malaria.

Conditions

  • Severe Malaria

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Medicines for Malaria Venture

    collaborator OTHER

  • Swiss Tropical & Public Health Institute

    lead OTHER

Principal Investigators

  • Christian Burri, PhD · Swiss Tropical & Public Health Institute

  • Antoinette Tshefu, MD · Kinshasa School of Public Health

Eligibility

Min Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Democratic Republic of the Congo

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01828333 on ClinicalTrials.gov